Advertisement

Hysteroscopy and Abnormal Uterine Bleeding (AUB)

  • Sergio Haimovich
  • Roberto LiguoriEmail author
Chapter
  • 63 Downloads

Abstract

Authors stressed the role of outpatient hysteroscopy in diagnosing abnormal uterine bleeding in women in a fertile age and in this regard they debated about the new classification of AUB (PALM COEIN).

The acronym PALM COEIN comes from arranging nine basic categories of the classification system. The PALM group comprises the structural entities which can be measured visually or by using imaging techniques and histopathology. The COEIN group comprises the nonorganic types which cannot be defined by imaging or histopathology.

Future randomized trials are needed in order to improve the diagnostic approach to AUB, a very frequent gynecologic consultation in daily practice.

Keywords

Abnormal uterine bleeding Hysteroscopy FIGO Classification PALM COEIN 

References

  1. 1.
    Woolcock JG, Critchley HO, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and definitions of disturbances of menstrual bleeding. Fertil Steril. 2008;890(6):2269–80.CrossRefGoogle Scholar
  2. 2.
    Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminology and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod. 2007;22(3):635–43.CrossRefGoogle Scholar
  3. 3.
    Munro MG, Critchley HO, Fraser IS. The FIGO classification system PALM COEIN of causes of abnormal uterine bleeding. Int J Gynecol Obstet. 2011;113:1–2.CrossRefGoogle Scholar
  4. 4.
    Madhra M, Fraser IS, Munro MG, Critckley HO. Abnormal uterine bleeding: advantages of formal classification to patients, clinicians and researchers. Acta Obstet Gynecol Scand. 2014;93(7):619–25.CrossRefGoogle Scholar
  5. 5.
    Toz E, Sanci M, Ozcan A, Beyan E, Inan AH. Comparison of classic terminology with the FIGO PALM COEIN system for classification of the underlying causes of abnormal uterine bleeding. Int J Gynaecol Obstet. 2016;133(3):325–8.CrossRefGoogle Scholar
  6. 6.
    Shubham D, Kawthalkar AS. Critical evaluation of the PALM COEIN classification system among women with abnormal uterine bleeding in low-resource settings. Int J Gynecol Obstet. 2018;141(2):217–21.CrossRefGoogle Scholar
  7. 7.
    Munro MG, Critchley HO, Fraser IS. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143:393–408.  https://doi.org/10.1002/ijgo.12666. [Epub ahead of print].CrossRefGoogle Scholar
  8. 8.
    Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN, Liberis VA. Endometrial polyps: prevalence, detection and malignant potential in women with abnormal uterine bleeding. Eur J Oncol. 2000;21(2):180–3.Google Scholar
  9. 9.
    Shusan A, Revel A, Rojansky N. How often are endometrial polyps malignant? Gynecol Obstet Invest. 2004;58(4):212–5.CrossRefGoogle Scholar
  10. 10.
    Daniele A, Ferrero A, Maggiorotto F, Perrini G, Volpi E, Sismondi P. Suspecting malignancy in endometrial polyps: value of hysteroscopy. Tumori. 2013;99(2):204–9.CrossRefGoogle Scholar
  11. 11.
    Gordts S, Brosens JJ, Fusi L, Benagiano G, Brosens I. Uterine adenomyosis: a need for uniform terminology and consensus classification. Reprod Med Online. 2008;17(2):244–8.CrossRefGoogle Scholar
  12. 12.
    Dueholm M. Transvaginal ultrasounds for diagnosis of adenomyosis: a review. Best Res Clin Obstet Gynaecol. 2006;20(4):569–82.CrossRefGoogle Scholar
  13. 13.
    Van den Bosch T, de Bruijn AM, de Leeuw RA, Dueholm M, Exacoustos C, Valentin L, Bourne T, Timmerman D, Houirne JAF. A sonographic classification and reporting system for diagnosis of adenomyosis. Ultrasound Obstet Gynecol. 2019;53:576–82.  https://doi.org/10.1002/uog.19096. [Epub ahead of print].CrossRefGoogle Scholar
  14. 14.
    Van den Bosch T, Dueholm M, Leone FP, Valentin L, Rasmussen CK, Votino A. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46(3):284–98.CrossRefGoogle Scholar
  15. 15.
    Dueholm M, Lundorf E, Hansen ES, Sorensen JS, Leterdoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril. 2001;676(3):588–94.CrossRefGoogle Scholar
  16. 16.
    Bazot M, Darai E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018;109(3):389–97.CrossRefGoogle Scholar
  17. 17.
    Champaneria R, Abedin P, Daniels J, Balogun M, Khan KS. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand. 2018;89(11):1374–84.CrossRefGoogle Scholar
  18. 18.
    Di Spiezio Sardo A, Calagna G, Santangelo F, Zizolfi B, Tanos V, Perino A, De Wilde RL. The role of hysteroscopy in the diagnosis and treatment of adenomyosis. Biomed Res Int. 2017;2017:2518396.CrossRefGoogle Scholar
  19. 19.
    Lasmar RB, Lasmar BP. The role of leiomyomas in the genesis of abnormal uterine bleeding. (AUB). Best Pract Res Clin Obstet Gynaecol. 2017;40:82–8.CrossRefGoogle Scholar
  20. 20.
    Munoz JL, Jimenez JS, Hernandez C, Vaquero G, Perez Sagaseta C, Noguero R, Miranda P, Hernandez JM, De la Fuente P. Hysteroscopic myomectomy: our experience and review. JSLS. 2003;7(1):39–48.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Casadio P, Guasina F, Morra C, Talamo MT, Leggieri C, Frisoni M, Seracchioli R. Hysteroscopic myomectomy: techniques and preoperative assessment. Minerva Ginecol. 2016;68(2):154–66.PubMedGoogle Scholar
  22. 22.
    Gawron I, Loboda M, Babczyk D, Ludwin I, Basta P, Pitynski K, Ludwin A. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling. Przegl Lek. 2017;74(4):139–43.PubMedGoogle Scholar
  23. 23.
    Lasmar RB, Barrozo PR, de Oliveira MA, Coutinho ES, Dias R. Validation of hysteroscopy view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding. J Minim Invasive Gynecol. 2006;13(5):409–12.CrossRefGoogle Scholar
  24. 24.
    Farquhar M, Lethaby A, Sowter M, Verry J, Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol. 1999;181(3):525–9.CrossRefGoogle Scholar
  25. 25.
    Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005;84(5):1345–51.CrossRefGoogle Scholar
  26. 26.
    Munro MG, Lukes AS. Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process. Fertil Steril. 2005;84(5):1335–7.CrossRefGoogle Scholar
  27. 27.
    Shankar M, Lee CA, Sabin CA, Economides DL, Kadur RA. von Willebrand disease in women with metrorrhagia: a systematic Review. BJOG. 2004;111(7):734–40.CrossRefGoogle Scholar
  28. 28.
    Smith SK, Abel MH, Kelly RW, Baird D. A role of prostacyclin in excessive menstrual bleeding. Lancet. 1981;1(8219):522–4.CrossRefGoogle Scholar
  29. 29.
    Smith SK, Abel MH, Kelly RW, Bairdt DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynecol. 1981;88(4):434–42.CrossRefGoogle Scholar
  30. 30.
    Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol. 1994;171(1):178–83.CrossRefGoogle Scholar
  31. 31.
    Munro MG. Dysfunctional uterine bleeding; advances in diagnosis and treatment. Curr Opin Obstet Gynecol. 2001;13(5):475–89.CrossRefGoogle Scholar
  32. 32.
    Heatley MK. The association between clinical and pathological features in histologically identified chronic endometritis. J Obstet Gynecol. 2004;24(7):801–3.CrossRefGoogle Scholar
  33. 33.
    Cox M, Tripp J, Blacksell S. Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5 years report. J Fam Plann Reprod Health Care. 2002;28(2):73–7.CrossRefGoogle Scholar
  34. 34.
    Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute bleeding: a randomized controlled trial. Obstet Gynecol. 2006;108(4):924–9.CrossRefGoogle Scholar
  35. 35.
    De Crem N, Peerlinck K, Vanassche T, Vanheule K, Debaveye B, Middeldorp S. Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists. Thromb Res. 2015;136(4):749–53.CrossRefGoogle Scholar
  36. 36.
    Calzolari S., Cozzolino M, Castellacci E. Le malformazioni uterine artero-venose. Chirurgia isteroscopica focus on. Ed. Laterza; 2017. pp. 203–16.Google Scholar
  37. 37.
    Sanguin S, Lanta-Delmas S, Le Blanche A, Grardel- Chambenoit E, Merviel P, Gondry J, Fauvet R. Uterine arteriovenous malformations: diagnosis and treatment. Gynecol Obstet Fertil. 2011;39(12):722–7.CrossRefGoogle Scholar
  38. 38.
    Yonn DJ, Jones M, Taani JA, Buhimschi C, Dowell JDA. Systematic review of acquired uterine arteriovenous malformations: pathophysiology, diagnosis and transcatheter treatment. AJP Rep. 2016;6(1):6–14.CrossRefGoogle Scholar
  39. 39.
    Tulandi T, Cohen H. Emerging manifestations of cesarean scar defects in reproductive-aged women. J Minim Invasive Gynecol. 2016;23(6):893–902.CrossRefGoogle Scholar
  40. 40.
    Bij de Vaate A, van der Voet LF, Naji O, Witmer M, Veersema S. Brolmann HA Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet Gynecol. 2014;43(4):372–82.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Gynecology Ambulatory Surgery, Hillel Yaffe Medical CenterHaderaIsrael
  2. 2.Hysteroscopy UnitDel Mar University HospitalBarcelonaSpain
  3. 3.Hysteroscopic Surgical CenterVismedBariItaly

Personalised recommendations